Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers

Fig. 3

Correlation between CTHRC1 mRNA expression and prognosis of cancers. a We used the GEPIA2 tool to perform overall survival and disease-free survival analyses of pan-cancer in TCGA by CTHRC1 mRNA expression; b The relationships between CTHRC1 expression and OS prognosis of different cancers in “Gene-KM plotter” module of SangerBox. The Kaplan–Meier plotter was performed survival analyses, including OS, DMFS, RFS, PPS, FP DSS, via the expression level of the CTHRC1 mRNA in breast cancer, liver cancer and lung cancer cases c, and OS, PFS, PPS, FP, via the expression level of the CTHRC1 mRNA in ovarian cancer and gastric cancer (d)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us